1. Home
  2. FPI vs PCRX Comparison

FPI vs PCRX Comparison

Compare FPI & PCRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.99

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo Pacira BioSciences Inc.

PCRX

Pacira BioSciences Inc.

HOLD

Current Price

$26.00

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
PCRX
Founded
2013
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
1.0B
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
FPI
PCRX
Price
$9.99
$26.00
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$32.86
AVG Volume (30 Days)
569.6K
876.5K
Earning Date
02-18-2026
02-26-2026
Dividend Yield
2.38%
N/A
EPS Growth
296.76
N/A
EPS
1.27
0.47
Revenue
$52,990,000.00
$716,791,000.00
Revenue This Year
N/A
$6.24
Revenue Next Year
N/A
$9.53
P/E Ratio
$7.90
$53.70
Revenue Growth
N/A
3.14
52 Week Low
$9.37
$18.17
52 Week High
$12.87
$27.64

Technical Indicators

Market Signals
Indicator
FPI
PCRX
Relative Strength Index (RSI) 51.45 57.02
Support Level $9.52 $24.20
Resistance Level $9.73 $26.81
Average True Range (ATR) 0.18 1.01
MACD 0.00 -0.15
Stochastic Oscillator 41.58 69.35

Price Performance

Historical Comparison
FPI
PCRX

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About PCRX Pacira BioSciences Inc.

Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.

Share on Social Networks: